What is Dihexa studied for?

Dihexa is primarily investigated in preclinical research involving HGF/c-Met signaling and neurological mechanisms.

Key research areas include:

• Synaptogenesis: Research examines Dihexa in relation to the formation of synaptic connections.
• Dendritic spine research: Experimental studies investigate changes in dendritic spine density and related neuronal structures.
• Cognitive and memory models: Dihexa has been explored in experimental models examining learning, memory, and cognitive function.
• Neurodegeneration research: Preclinical investigations have examined the compound in models relevant to neurodegenerative processes.
• CNS injury research: Dihexa has also been investigated in experimental models involving conditions such as traumatic brain injury and stroke.

These are areas of preclinical investigation. Findings from experimental models should not be interpreted as evidence that Dihexa provides a clinical benefit or is appropriate for treating neurological conditions in humans.

How does Dihexa relate to HGF/c-Met signaling?

Dihexa is described as an HGF mimetic, making the HGF/c-Met pathway central to its research profile.

Laboratory research examines how activity associated with this signaling pathway relates to processes such as synaptogenesis and neuronal structural changes. This provides the mechanistic basis for much of the scientific interest surrounding Dihexa.

What makes Dihexa different from peptide research materials?

One important distinction is that Dihexa is a small-molecule peptidomimetic rather than a conventional peptide.

Its structure is listed as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, and the product has a reported molecular mass of 504.66 g/mol.

For researchers comparing different research compounds, recognizing this molecular classification helps avoid treating Dihexa as interchangeable with conventional peptide materials.

Why choose this Dihexa research material?

Researchers evaluating Dihexa peptide buy options should first note that Dihexa is technically a small-molecule peptidomimetic, despite the peptide-related terminology often used in research searches.

The supplied material has a stated purity of ≥99% by HPLC, is provided as a lyophilized powder, and has clearly identified molecular specifications, including its CAS number, molecular formula, molar mass, and structural description.

These details provide useful reference points when reviewing the material for a laboratory research application.

Storage and handling

The supplied specifications indicate −20°C (−4°F) for long-term storage and 2–8°C (36–46°F) after reconstitution.

Bacteriostatic water for laboratory use is listed under the supplied solubility information.

Researchers should follow the applicable product documentation and laboratory protocols for storage, handling, and preparation. The appropriate handling procedure should be determined according to the research application and laboratory requirements.

What should researchers know before ordering?

If you are evaluating Dihexa online or comparing a supplier, review the product's molecular identity and specifications rather than relying on broad terms such as “nootropic peptide.”

Dihexa is specifically identified as a small-molecule peptidomimetic with CAS number 1401708-83-5, molecular formula C27H44N4O5, and stated purity of ≥99% HPLC.

Researchers should also distinguish preclinical research findings from established human applications. This material is supplied for laboratory research only and is not intended as a medication, supplement, nootropic product, or treatment.

Frequently asked questions

What is Dihexa?

Dihexa is a small-molecule peptidomimetic and HGF mimetic derived from angiotensin IV. It is studied in preclinical research involving HGF/c-Met signaling, synaptogenesis, dendritic spine formation, and neurological models.

Is Dihexa a peptide?

Dihexa is a small-molecule peptidomimetic, not a conventional peptide. It is nevertheless frequently described using peptide-related terminology because of its peptidomimetic structure and research context.

What is Dihexa studied for?

Preclinical research examines Dihexa in areas including synaptogenesis, dendritic spine growth, cognitive and memory models, neurodegeneration research, and experimental CNS injury models.

What pathway is associated with Dihexa research?

Dihexa is investigated as an HGF mimetic, with research focusing on activity associated with the HGF/c-Met signaling pathway.

What is the CAS number for Dihexa?

The listed CAS number is 1401708-83-5.

What is the molecular formula of Dihexa?

The supplied molecular formula is C27H44N4O5.

What is the molar mass of Dihexa?

The listed molar mass is 504.66 g/mol.

What is the purity of Dihexa?

The specified purity is ≥99% by HPLC.

What form is Dihexa supplied in?

Dihexa is supplied as a lyophilized powder.

How should Dihexa be stored?

The supplied specification lists −20°C (−4°F) for long-term storage and 2–8°C (36–46°F) after reconstitution.

Is Dihexa intended for human use?

No. This product is intended for laboratory research only and is not for human or veterinary consumption.

Product overview

Dihexa is a small-molecule peptidomimetic and HGF mimetic investigated in preclinical research involving HGF/c-Met signaling, synaptogenesis, dendritic spine growth, and neurological models.

The material is supplied as a lyophilized powder with ≥99% HPLC purity and has a reported CAS number of 1401708-83-5, molecular formula of C27H44N4O5, and molar mass of 504.66 g/mol.

For researchers evaluating a Dihexa research material, its defined molecular identity, structural description, purity, physical form, and storage specifications provide the essential information needed for informed laboratory evaluation.

For laboratory research only. Not for human or veterinary consumption.

This statement has not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.